Microbiology And Immunology

Projects

Projects per year 2003 2014 2016 2017 2020 2027

• 355 Active
• 1023 Completed

Projects per year

Search results

• Advancement of Vaccines and Therapies for Henipaviruses

  Geisbert, T.

  3/20/19 → 2/28/23

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/8/19 → 2/29/24

  Project: Other project

• Aerus ActivePure Air Purifier Against Respiratory Pathogens

  Lawrence, W.

  ActivePure Medical LLC

  3/1/21 → 11/1/22

  Project: Other project

• Air Purification of Airborne SARS-CoV-2 by Genesis Air Technology

  Lawrence, W.

  Genesis Air Inc

  4/1/21 → 11/1/22

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Assays in Support of Filovirus Nonhuman Primate Studies for Advancement of Medical

  Comer, J.

  2/10/22 → 9/2/24

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  4/16/20 → 4/1/23

  Project: Other project

• Authentic Live Virus Assay (up to 50 samples tested); Lilly #1

  Geisbert, T.

  Eli Lilly & Company

  4/16/20 → 4/1/23

  Project: Other project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T.

  3/27/19 → 9/30/22

  Project: Other project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T.

  3/27/19 → 9/30/22

  Project: Other project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T.

  3/27/19 → 9/30/22

  Project: Other project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T.

  3/27/19 → 9/30/22

  Project: Other project

• A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera

  Geisbert, T.

  3/27/19 → 9/30/22

  Project: Other project

• Bepridil as a COVID-19 Therapeutics: A Rapid, Low-Cost Solution to the Current Pandemic

  Tseng, C.

  Texas A&M University System

  1/1/21 → 7/14/22

  Project: Other project

• Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

  Tseng, C.

  8/9/17 → 7/31/22

  Project: Other project

• CEPI NC3R High Containment Studies to Support Product Development

  Beasley, D.

  10/1/21 → 8/31/23

  Project: Other project

• Clinical Study Protocol for COVID-19 Antigen Test - Omicron Variant

  Tseng, C.

  1/24/22 → 1/23/23

  Project: Other project

• C-type Lectin Receptor Pathways in Pathogenesis of TB/HIV Co-Infection

  Endsley, J.

  National Inst of Allergy & Infectious Di

  5/5/20 → 4/30/23

  Project: Other project

• C-type Lectin Receptor Pathways in Pathogenesis of TB/HIV Co-Infection

  Endsley, J.

  5/5/20 → 4/30/23

  Project: Other project

• C-type Lectin Receptor Pathways in Pathogenesis of TB/HIV Co-Infection

  Endsley, J.

  National Inst of Allergy & Infectious Di

  5/5/20 → 4/30/23

  Project: Other project

• Data science and genomic approach to mitigate arboviruses in the current era of climate change

  De Souza, W.

  6/1/22 → 5/31/23

  Project: Other project

• Defining the role of toxin-antitoxin systems in persistence of Burkholderia pseudomallei

  Torres, A.

  6/16/20 → 5/31/23

  Project: Other project

• Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2

  Geisbert, T.

  10/1/21 → 8/31/22

  Project: Other project

• Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2

  Geisbert, T.

  10/1/21 → 8/31/22

  Project: Other project

• Developing effective nanovaccines against pathogenic Escherichia coli

  Torres, A.

  6/1/21 → 5/31/23

  Project: Other project

• Development of an aerosol induced nonhuman primate model of Lassa fever

  Geisbert, T.

  7/30/21 → 8/31/26

  Project: Other project

• Development of an aerosol induced nonhuman primate model of Lassa fever

  Geisbert, T.

  7/30/21 → 8/31/26

  Project: Other project